Boston Scientific Corporation (BSX)

Boston Scientific Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	113,191	141,351	131,642	84,691	66,273	60,534
Market Cap Growth	-24.97%	7.38%	55.44%	27.79%	9.48%	17.59%
Enterprise Value	123,198	152,357	140,646	93,281	74,869	68,049
Last Close Price	76.28	95.35	89.32	57.81	46.27	42.48
PE Ratio	39.32	48.78	71.04	53.94	103.23	61.46
Forward PE	22.02	28.71	33.08	26.76	24.51	23.73
PS Ratio	5.64	7.04	7.86	5.95	5.23	5.09
PB Ratio	4.67	5.98	5.98	4.34	3.77	3.64
P/FCF Ratio	-	-	49.77	47.26	70.65	46.00
P/OCF Ratio	24.96	-	38.32	33.84	43.43	32.37
PEG Ratio	1.30	1.65	2.42	2.19	2.30	1.64
EV/Sales Ratio	6.14	7.59	8.40	6.55	5.90	5.72
EV/EBITDA Ratio	23.08	27.21	32.93	25.82	23.63	23.33
EV/EBIT Ratio	31.02	35.74	46.85	38.59	36.83	37.31
EV/FCF Ratio	-	-	53.17	52.05	79.82	51.71
Debt / Equity Ratio	0.51	0.51	0.51	0.49	0.53	0.57
Debt / EBITDA Ratio	2.15	2.15	2.57	2.58	2.87	3.17
Debt / FCF Ratio	-	-	4.25	5.34	9.96	7.24
Net Debt / Equity Ratio	0.46	0.46	0.49	0.45	0.48	0.46
Net Debt / EBITDA Ratio	1.92	1.92	2.53	2.41	2.66	2.61
Net Debt / FCF Ratio	-	-	4.09	4.86	8.97	5.78
Asset Turnover	-	-	0.45	0.42	0.39	0.38
Inventory Turnover	-	-	2.00	2.02	2.30	2.54
Quick Ratio	-	-	0.46	0.63	0.76	0.87
Current Ratio	-	-	1.08	1.32	1.52	1.48
Return on Equity (ROE)	12.68%	12.68%	8.89%	8.58%	4.08%	6.52%
Return on Assets (ROA)	-	-	5.04%	4.47%	3.93%	3.62%
Return on Invested Capital (ROIC)	10.59%	10.84%	7.96%	7.15%	4.95%	7.43%
Return on Capital Employed (ROCE)	-	-	9.10%	8.00%	7.10%	6.50%
Earnings Yield	2.56%	2.05%	1.41%	1.88%	1.05%	1.72%
FCF Yield	-	-	2.01%	2.12%	1.42%	2.17%
Payout Ratio	-	-	-	1.76%	7.88%	5.28%
Buyback Yield / Dilution	-0.58%	-0.58%	-1.53%	-1.65%	-0.41%	-1.21%

Updated Feb 4, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q